On August 27, 2025 Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, reported that members of the executive management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sept. 9, at 7:45 am ET (Press release, LabCorp, AUG 27, 2025, View Source [SID1234655515]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.

On August 27, 2025 Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, reported that management is scheduled to participate in a fireside chat on September 4, 2025 at the 2025 Wells Fargo Healthcare Conference in Boston, MA (Press release, Geron, AUG 27, 2025, View Source [SID1234655514]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available at ir.geron.com and will be posted on the Investors and Media section of Geron’s website. The webcast will be archived and available for replay for 30 days following the event.

On August 27, 2025 FORE Biotherapeutics reported that the Company will participate at the following investor conferences (Press release, Fore Biotherapeutics, AUG 27, 2025, View Source [SID1234655513]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Healthcare Conference. The Company will attend on Wednesday, September 3, and will provide a corporate presentation at 12:45 p.m. – 1:20 p.m. ET.
Cantor Fitzgerald Global Healthcare Conference. The Company will attend and participate in one-on-one meetings on Thursday, September 4.
Management will host and participate in one-on-one meetings. Please contact Argot Partners to schedule one-on-one meetings with the management team.

On August 27, 2025 FibroGen, Inc. (NASDAQ: FGEN) reported that the Company will be attending and presenting at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025, in New York, NY (Press release, FibroGen, AUG 27, 2025, View Source [SID1234655512]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Thane Wettig, Chief Executive Officer of FibroGen, will deliver a company presentation on Tuesday, September 9 at 12:00 PM ET at the Lotte New York Palace Hotel. A live webcast of the presentation will be available here.

FibroGen’s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. A replay of the presentation will be posted, when available, to the FibroGen website on the Events & Presentation page of the Investors and Media section for 90 days.

On August 27, 2025 Exelixis, Inc. (Nasdaq: EXEL) reported that company management will participate in fireside chats at the following investor conferences in September (Press release, Exelixis, AUG 27, 2025, View Source [SID1234655511]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Wells Fargo Healthcare Conference: Exelixis is scheduled to present at 12:45 p.m. ET / 9:45 a.m. PT on Wednesday, September 3 in Everett, MA.
Citi’s 2025 Biopharma Back to School Conference: Exelixis is scheduled to present at 3:15 p.m. ET / 12:15 p.m. PT on Wednesday, September 3 in Boston.
Morgan Stanley 23rd Annual Global Healthcare Conference: Exelixis is scheduled to present at 8:30 a.m. ET / 5:30 a.m. PT on Tuesday, September 9 in New York City.
H.C. Wainwright 27th Annual Global Investment Conference: Exelixis is scheduled to present at 8:00 a.m. ET / 5:00 a.m. PT on Wednesday, September 10 in New York City.
Bernstein’s 2nd Annual Healthcare Forum: Exelixis is scheduled to present at 8:50 a.m. ET / 5:50 a.m. PT on Wednesday, September 24 in New York City.

To access the webcast links, log onto www.exelixis.com and proceed to the Event Calendar page under the Investors & News heading. Replays will also be available at the same location for at least 30 days.